SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ahlcon Parenterals to commence commercial production at Bhiwadi plant in December

15 May 2014 Evaluate

Ahlcon Parenterals (India) has initiated programme for expansion of capacities, at its existing Bhiwadi plant in Rajasthan, the estimated cost of which is approximately Rs 190 crore, to be met through debts / internal accruals. The company expects to commence commercial production in quarter ended December 2014.

Ahlcon Parenterals (India) manufactures pharmaceutical intravenous (I.V.) fluids, medical disposables, and opthalmics/ear drops. It offers I.V. fluids, antimicrobial I.V. fluids, plasma volume expanders in BFS bottles, and nasal drops.

Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×